Nichi-Iko Pharmaceutical Co., Ltd.

    Text Size

    • S
    • M
    • L
    • Japanese
    • English

  • About Us
    Corporate Information
    Corporate Information
    What is Premium Quality ?
    What is Premium Quality ?
    The 8th Mid-term Business Plan
    The 8th Mid-term
    Business Plan
  • Product Information
    Products in JAPAN
    Products in JAPAN
    Products in ASIA
    Products in ASIA
  • Investor Relations
    IR News
    IR News
    Management Vision
    Management Vision
    Highlights of Financial Results
    Highlights of Financial Results
    IR Information Office
    IR Information Office
    Shareholder / Share Information
    Shareholder /
    Share Information
     IR Calendar
    IR Calendar
    Shared Research Report
    Shared Research Report
     IR Calendar
    Integrated Report
    • Risk Information
    • Disclaimers
    • IR Inquiry
  • CSR
    Basic Policy
    Basic Policy
    Ecology
    Ecology
    Community
    Community
    Human Rights
    Human Rights
Nichi-Iko Pharmaceutical Co., Ltd.

  • About Us
  • Product Information
  • Investor Relations
  • CSR
  • Japanese
  • English

HOME

  1. Investor Relations
  2. Top

IRINVESTOR RELATIONS

Investor Relations Global Top 10 Generic Pharmaceutical Company

IR NEWS

  • 05/17/2022 withLink Notice Regarding Change in Representative Board Member and Officer Appointments pdf (124KB)

  • 05/17/2022 withLink Notice of the Execution of Basic Agreement on Investment with Japan Industrial Solutions III Investment Limited pdf (151KB)

  • 05/17/2022 withLink Notice of Formal Application and Acceptance of Business Turnaround ADR pdf (151KB)

  • 05/17/2022 withLink Notice of Recording of Inventory Assets Appraisal Loss and Impairment Loss, Difference between Forecast of Full-Year Consolidated Results and Actual Results and Difference of Individual Financial Results Compared to Actual Results for the Previous Fiscal Year pdf (208KB)

  • 03/09/2022 withLink Consolidated Financial Result for the 3rd Quarter of the Fiscal Year Ending March,2022(IFRS) pdf (309KB)

全てのニュース

IR NEWS

IR NEWS

MANAGEMENT VISION

MANAGEMENT VISION

HIGHLIGHTS OF FINANCIAL RESULTS

HIGHLIGHTS OF FINANCIAL RESULTS

IR INFORMATION OFFICE

IR INFORMATION OFFICE

SHAREHOLDER/SHARE INFORMATION

SHAREHOLDER/SHARE INFORMATION

IR CALENDAR

IR CALENDAR

MEDIUM-TERM BUSINESS PLAN

MEDIUM-TERM BUSINESS PLAN

SHARED RESEARCH REPORT

SHARED RESEARCH REPORT

INTEGRATED REPORT

INTEGRATED REPORT

RISK INFORMATION

DISCLAIMER

IR CONTACT

PAGETOP
  • About Us
    • Corporate Information
      • Corporate Profile
      • Company Brochure(PDF)
      • Corporate History
      • Organization
      • Offices
    • What is Premium Quality ?
      • Development Structure
      • Production Structure
      • Distribution Structure
      • Quality Assurance Structure
      • Information Provision Structure
    • The 8th Mid-term
      Business Plan
  • Product Information
    • Products in JAPAN
      • Oral Drugs Design
      • Packagings Design
      • External Drugs Design
      • A-Z List of Our Products /
        Kusuri-no-Shiori®
    • Products in ASIA
      • Hong Kong
      • Thailand
      • Malaysia
      • Vietnum
      • Phillipine
      • Singapole
  • Investor Relations
    • IR News
    • Management Vision
    • Highlights of Financial Results
    • IR Information Office
    • Shareholder / Share Information
    • IR Calendar
    • Shared Research Report
    • Risk Information
    • Disclaimers
    • IR Inquiry
  • CSR
    • Basic Policy
    • Ecology
    • Community
    • Human Rights
  • Site Map

Copyright 2018 Nichi-Iko Pharmaceutical Co., Ltd. All Rights Reserved.